SEC Company Response from Jasper Therapeutics, Inc. (JSPR, JSPRW) (CIK 0001788028) (JSPR) — Nov 18, 2019

Jasper Therapeutics, Inc. (JSPR, JSPRW) (CIK 0001788028)
Date: Nov. 18, 2019 · CIK: 0001788028 · Accession: 0001213900-19-023829

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-234324

Date

November 18, 2019

Author

/s/ Bala Venkataraman

Form

CORRESP

Company

Jasper Therapeutics, Inc. (JSPR, JSPRW) (CIK 0001788028)

Letter

VIA EDGAR Division of Corporation Finance Re: Amplitude Healthcare Acquisition Corporation Registration Statement on Form S-1 Filed October 25, 2019, as amended File No. 333-234324

Dear Ms. Block:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Amplitude Healthcare Acquisition Corporation hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4 p.m. EST on Tuesday, November 19, 2019, or as soon as thereafter practicable.

Very truly yours,
/s/ Bala Venkataraman

Show Raw Text

CORRESP
1
filename1.htm

AMPLITUDE HEALTHCARE ACQUISITION CORPORATION

1177 Avenue of the Americas, Floor 40

New York, NY 10036

November 18, 2019

VIA EDGAR

Ms. Susan Block

Division of Corporation Finance

U.S. Securities & Exchange
Commission

100 F Street, NE

Washington, D.C. 20549-4561

    Re:
    Amplitude Healthcare Acquisition Corporation

    Registration Statement on Form S-1

    Filed October 25, 2019, as amended

    File No. 333-234324

Dear Ms. Block:

Pursuant to Rule 461 under the Securities Act
of 1933, as amended, Amplitude Healthcare Acquisition Corporation hereby requests acceleration of effectiveness of the above referenced
Registration Statement so that it will become effective at 4 p.m. EST on Tuesday, November 19, 2019, or as soon as thereafter practicable.

    Very truly yours,

    /s/ Bala Venkataraman

    Bala Venkataraman

    Chief Executive Officer

    cc:

        Ellenoff Grossman & Schole LLP

        Mayer Brown LLP

SecProbe.io